Response of RGC to Optic Nerve Injury
About the Research Project
Program
Award Type
Standard
Award Amount
$30,000
Active Dates
April 01, 2000 - March 31, 2001
Grant ID
G2000031
Summary
Abnormalities in the processes of retinal ganglion cells (RGCs) can lead to cell death and vision loss. One of the signals that may lead to cell death in RGCs is an influx of calcium. Dr. Keirstead has developed a surgical procedure to examine retinal ganglion cells in vivo in an anesthetized mouse. In a previous study funded by NGR, she made progress in developing a method of labeling ganglion cells with a dye that allows her to measure changes in the cells’ calcium concentration. Her current goal is to optimize this method of examining changes in calcium in response to nerve cell damage. The further refinement of this method will allow Dr. Keirstead to directly assess the role of calcium in optic nerve damage, and to test the effects of various drugs on this process.
Grants
Related Grants
National Glaucoma Research
Saving Sight: A Journey to Healing Without Scars
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Jennifer Fan Gaskin, FRANZCO
Saving Sight: A Journey to Healing Without Scars
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Jennifer Fan Gaskin, FRANZCO
National Glaucoma Research
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Diana C. Lozano, PhD
IOP-Related Gene Responses in the Optic Nerve Head and Trabecular Meshwork
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Diana C. Lozano, PhD
National Glaucoma Research
The Impact of Glaucoma on Light-Mediated Mood and Sleep Disorders
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Xiaorong Liu, PhD
The Impact of Glaucoma on Light-Mediated Mood and Sleep Disorders
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Xiaorong Liu, PhD